logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Martin H. Voss

Memorial Sloan Kettering Cancer Center

55H指数
571论文数
2.3W被引数
收录论文 111
发表时间
logo
78 Dietary Fructose Intake and Tumoral Fructose-Metabolism Gene Expression in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Blockade78 饮食果糖摄入与接受免疫检查点阻断治疗转移性肾细胞癌的肿瘤果糖代谢基因表达
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errAntonio Ocejo; Stanley Liang; Carlene Gonzalez; Allen Mena; Nicholina Metzer; Cihan Duzgol; Jeeban P Das; Ashley Regazzi; Bradley Reinfeld; Sahil D Doshi; Phillip Rappold; Maria I Carlo; Darren R Feldman; Neil J Shah; Jonathan E Rosenberg; Robert J Motzer; Gopa Iyer; Martin H Voss; Ritesh R Kotecha; Brendan J Guercio
err分享
err收藏
85 Phase 3 LITESPARK-033 (NCT07227402) Study of Belzutifan Plus Zanzalintinib Versus Cabozantinib for Recurrent Clear Cell Renal Cell Carcinoma During or After Adjuvant Anti–PD-(L)1 Therapy85 LITESPARK-033（NCT07227402）III期研究：比较贝舒替班联合赞赞林替尼与卡博赞替尼治疗接受辅助抗PD-(L)1治疗后复发透明细胞肾细胞癌的疗效
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errToni K Choueiri; Thomas Powles; Martin H Voss; Marc-Oliver Grimm; Kelly N Fitzgerald; Brian Simmons; Jerry Cornell; Joseph E Burgents; Priyanka Chablani; Cristina Suarez
err分享
err收藏
81 Tumor-Informed Circulating Tumor DNA Monitoring in Fumarate Hydratase–Deficient Renal Cell Carcinoma81 基于肿瘤信息的循环肿瘤DNA监测在富马酸水合酶缺乏型肾细胞癌中的应用
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errAntonio Ocejo; Andrea Knezevic; Ayaa Essafi; Sahil D Doshi; Andrew Cornish; Neil J Shah; David H Aggen; Robert J Motzer; A Ari Hakimi; Darren R Feldman; Ritesh R Kotecha; Martin H Voss; Maria I Carlo
err分享
err收藏
From diversity to function: microbiome precision in RCC从多样性到功能：RCC中微生物组的精准性
errNature Reviews Urology
IF14.6
err2026-04-08
err0
PREAI
errAntonio Ocejo; Ritesh R. Kotecha; Martin H. Voss
err分享
err收藏
Mechanistic insights make cancer cachexia a targetable syndrome机械见解使癌症恶病质成为可靶向的综合症
errNature Medicine
IF50
err2026-01-02
err0
PREAI
errEd Reznik; Martin H. Voss; A. Ari Hakimi
err分享
err收藏
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers高级泌尿肿瘤共识会议（AUC3）2025：肾细胞癌和尿路肿瘤管理的专家共识
errCA: A Cancer Journal for Clinicians
IF0
err2025-12-13
err0
errOAAI
errRana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
err分享
err收藏
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy alone单纯局部治疗后转移性透明细胞肾细胞癌的长期肿瘤学结果
errUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
err2025-12-01
err0
PREAI
errBarbakoff, Daniel; Dawidek, Mark T.; Knezevic, Andrea; Ganz, Marc; Posada, Lina; Khandwala, Yash; Sanmiguel, Andrea Lopez; Reese, Stephen W.; Oparanozie, Arnold; Liso, Nicole; Kotecha, Ritesh R.; Motzer, Robert J.; Reznik, Ed; Coleman, Jonathan; Ostrovnaya, Irina; Voss, Martin H.; Russo, Paul; Hakimi, A. Ari
err分享
err收藏
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma病理反应与接受延迟性肾切除术的转移性肾细胞癌患者的生存期相关
errEuropean Urology Oncology
IF9.3
err2025-11-26
err0
PREAI
errYash S. Khandwala; Stephen W. Reese; Burcin A. Ucpinar; Andrea Knezevic; Lennert Eismann; Chih-Ying Wu; Rohan Mittal; Sahil Doshi; Daniel Barbakoff; Andrea Lopez Sanmiguel; Jonathan Coleman; Mark Dawidek; Robert J. Motzer; Paul Russo; Oguz Akin; Ritesh R. Kotecha; Ying-Bei Chen; Martin H. Voss; A. Ari Hakimi
err分享
err收藏
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell CarcinomaMLH1错配修复缺陷预测透明细胞肾细胞癌对免疫检查点抑制的显著反应
errEuropean Urology
IF25.2
err2025-11-04
err0
PREAI
errMark T. Dawidek; Lina Posada Calderon; Parantu K. Shah; Rohan Mittal; Burcin Agridag Ucpinar; Ziad Bakouny; Kevin Meli; Eddy Saad; Renée-Maria Saliby; H. Jun Woo; Yash S. Khandwala; Marc Eid; Chris Labaki; Marc Machaalani; Jonathan Coleman; Paul Russo; Ritesh R. Kotecha; Maria I. Carlo; Oguz Akin; David A. Braun; Toni K. Choueiri; Ed Reznik; Ying-Bei Chen; Robert J. Motzer; Martin H. Voss; A. Ari Hakimi
err分享
err收藏
Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinoma与免疫检查点阻断反应相关的肾细胞癌高级别放射组学生物标志物
errUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
err2025-11-01
err0
PREAI
errReese, Stephen W.; Barbakoff, Daniel; Ucpinar, Burcin Agridag; Knezevic, Andrea; Fitzgerald, Kelly; Eismann, Lennert; Tehrani, Yousef Mazaheri; Arroyave, Juan Sebastian; Khaleel, Sari; Khandwala, Yash S.; Dawidek, Mark; Motzer, Robert J.; Voss, Martin H.; Russo, Paul; Akin, Oguz; Kotecha, Ritesh R.; Hakimi, A. Ari
err分享
err收藏
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling通过整合基因组学和转录组学分析鉴定肾髓质癌的治疗靶点
errCell Reports Medicine
IF10.6
err2025-10-30
err0
errOAAI
errPavlos Msaouel; Nizar M. Tannir; Funda Meric-Bernstam; Jennifer M. King; Martin H. Voss; Jessica P. Cheng; Susan S. Thomas; Zita D. Lim; Menuka Karki; Rong He; Giannicola Genovese; Rahul A. Sheth; Davis R. Ingram; Diana Shamsutdinova; Khalida M. Wani; Wei-Lien Wang; Alexander J. Lazar; Dominique Knipper-Davis; Amber Berlinski; Tayla Soares; Danil Stupichev; Kirill Kryukov; Suren Davitavyan; Anna Novokreshchenova; Dmitry Lebedev; Stanislav Kurpe; Andrey Kravets; Dmitrii Belousov; Michael Hensley; Alexander Bagaev; Francesca Paradiso; Vladimir Kushnarev
err分享
err收藏
Subgroup analysis of the efficacy and safety of cabozantinib ± atezolizumab in patients from CONTACT-03 who received first-line treatment with immuno-oncology-based combinations卡博替尼±阿替利珠单抗在CONTACT-03研究中接受以免疫肿瘤为基础的联合方案一线治疗患者的疗效和安全性亚组分析
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errMcgregor, Bradley A.; Suarez, Cristina; Choueri, Toni; Albiges, Laurence; Voss, Martin; Khan, Omara; Williamson, Denise; Ricardo Perez, Jose; Hall, Tasha; Pal, Sumanta
err分享
err收藏
Pembrolizumab plus lenvatinib for previously untreated advanced non-clear cell renal cell carcinoma: 3-year follow-up of the phase 2 KEYNOTE-B61 study帕博利珠单抗联合仑伐替尼用于初治的透明细胞肾细胞癌以外的晚期肾细胞癌：KEYNOTE-B61研究的3年随访结果
errONCOLOGIST
IF4.2
err2025-10-01
err2
errOAAI
errAlbiges, Laurence; Gurney, Howard; Lee, Jae Lyun; Atduev, Vagif; Suarez, Cristina; Climent, Miguel A.; Pook, David; Tomczak, Piotr; Barthelemy, Philippe; Gedye, Craig; Lacombe, Louis; Ferguson, Thomas; Stus, Viktor; Wiechno, Pawel; Erman, Mustafa; Urun, Yuksel; Cornell, Jerry; Burgents, Joe; Sharma, Manish; Voss, Martin
err分享
err收藏
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank开发生物标志物和风险分层方法：国际肾癌研讨会北美2024年思辨研讨会的共识声明
errUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
err2025-09-01
err0
PREAI
errShapiro, Daniel D.; Abel, Edwin Jason; Albiges, Laurence; Battle, Dena; Berg, Stephanie A.; Campbell, Matthew T.; Cella, David; Coleman, Katie; Garmezy, Benjamin; Geynisman, Daniel M.; Hall, Tasha; Henske, Elizabeth P.; Jonasch, Eric; Karam, Jose A.; La Rosa, Salvatore; Leibovich, Bradley C.; Maranchie, Jodi K.; Master, Viraj A.; Maughan, Benjamin L.; Mcgregor, Bradley A.; Msaouel, Pavlos; Pal, Sumanta K.; Perez, Jose; Plimack, Elizabeth R.; Psutka, Sarah P.; Riaz, Irbaz B.; Rini, Brian I.; Shuch, Brian; Simon, Marie Celeste; Singer, Eric A.; Smith, Andrew; Staehler, Michael; Tang, Chad; Tannir, Nizar M.; Vaishampayan, Ulka; Voss, Martin H.; Zakharia, Yousef; Zhang, Qing; Zhang, Tian; Carlo, Maria I.
err分享
err收藏
First-line Pembrolizumab Plus Lenvatinib for Advanced Non–clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial一线帕博利珠单抗联合伦伐替尼治疗晚期非透明细胞肾细胞癌：KEYNOTE-B61 II期试验的更新结果
errEuropean Urology
IF25.2
err2025-07-24
err0
PREAI
errMartin H. Voss; Howard Gurney; Vagif Atduev; Cristina Suarez; Miguel A. Climent; David Pook; Piotr Tomczak; Philippe Barthélémy; Jae Lyun Lee; Taron Nalbandian; Viktor Stus; Thomas Ferguson; Pawel Wiechno; Erhan Gokmen; Louis Lacombe; Craig Gedye; Jerry Cornell; Manish Sharma; Joseph E. Burgents; Laurence Albiges
err分享
err收藏
Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinomaI期b/II期研究：评估batiraxcept单药及联合cabozantinib（无论是否联合nivolumab）治疗晚期透明细胞肾细胞癌的疗效。
errONCOLOGIST
IF4.2
err2025-06-01
err0
PREAI
errBeckermann, Kathryn E.; Shah, Neil J.; Campbell, Matthew T.; Haas, Naomi B.; Nelson, Ariel; Ornstein, Moshe C.; Mao, Shifeng; Keshava-Prasad, Holavanahalli S.; Hammers, Hans; Gao, Xin; Gourdin, Theodore; George, Saby; Hoimes, Christopher J.; Hussain, Arif; Jonasch, Eric; Rini, Brian, I; Voss, Martin H.
err分享
err收藏
A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma一项关于talazoparib和axitinib治疗晚期透明细胞肾细胞癌的1b/2期研究
errEuropean Urology Oncology
IF9.3
err2025-03-29
err0
PREAI
errRitesh R. Kotecha; Sahil D. Doshi; Andrea Knezevic; Rachel Jacobi; Hyung Jun Woo; David H. Aggen; Deaglan J. McHugh; Neil J. Shah; Maria I. Carlo; Niamh M. Keegan; Yogini Gayadin; Joshua Chaim; Mark T.A. Donoghue; Gopa Iyer; Chung-Han Lee; Darren R. Feldman; Robert J. Motzer; Martin H. Voss
err分享
err收藏
Clinicopathologic and Molecular Features Associated with Chromophobe Renal Cell Carcinoma Progression
errLABORATORY INVESTIGATION
IF4.2
err2025-03-01
err0
PREAI
errRammal, Rayan; Chen, Jie-Fu; Al-Ahmadie, Hikmat; Fine, Samson; Gopalan, Anuradha; Sarungbam, Judy; Tickoo, Satish; Hakimi, A.; Voss, Martin; Reuter, Victor; Chen, Ying-Bei
err分享
err收藏
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial (vol 86, pg 90, 2024)卡博替尼联合纳武利尤单抗治疗非透明细胞肾细胞癌：一项II期试验的更新结果（卷86，页90，2024）
errEUROPEAN UROLOGY
IF25.2
err2025-01-01
err0
PREAI
errFitzgerald, Kelly N.; Lee, Chung-Han; Voss, Martin H.; Carlo, Maria I.; Knezevic, Andrea; Peralta, Laura; Chen, Yingbei; Lefkowitz, Robert A.; Shah, Neil J.; Owens, Colette N.; Mchugh, Deaglan J.; Aggen, David H.; Laccetti, Andrew L.; Kotecha, Ritesh R.; Feldman, Darren R.; Motzer, Robert J.
err分享
err收藏
Management of Kidney Cancer Relapse to Adjuvant Pembrolizumab: Early Insights and Questions for a Newly Emerging Space肾癌复发后接受辅助性帕博利珠单抗治疗的管理：早期见解与新兴领域的问题
errEUROPEAN UROLOGY
IF25.2
err2024-12-01
err0
PREAI
errVoss, Martin H.; Motzer, Robert J.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
C
Chris Sander
H 指数: 191 · 论文数: 849
C
Charles S. Fuchs
H 指数: 171 · 论文数: 1.7K
H
Howard I. Scher
H 指数: 164 · 论文数: 1.4K
N
Nikolaus Schultz
H 指数: 162 · 论文数: 1.8K
V
Victor E. Reuter
H 指数: 153 · 论文数: 963
查看更多